Literature DB >> 3494855

Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response.

D Moskophidis, S P Cobbold, H Waldmann, F Lehmann-Grube.   

Abstract

After intravenous infection of mice, lymphocytic choriomeningitis virus multiplied in spleens and livers, attaining highest concentrations on days 4 to 6. The subsequent clearance was as rapid, and 8 to 10 days after inoculation, infectivity was usually below detectability. During the effector phase of virus elimination, both cytotoxic T-cell (CTL) activity and the number of cells producing antiviral antibodies were high. Monoclonal antibodies directed against T lymphocytes and T-lymphocyte subsets were inoculated once intravenously 5, 6, or 7 days after infection of the animals, and the effects on antiviral immune responses, as well as on elimination of virus from the organs, were determined. Treatment with anti-Thy-1 and anti-Lyt-2 antibodies blocked elimination of the virus and profoundly diminished the activity of spleen CTLs but reduced the antibody response partially (anti-Thy-1) or increased it (anti-Lyt-2). In contrast, treatment with the anti-L3T4 antibody had essentially no effect on either virus elimination or CTL response but abolished antibody production. We conclude that Lyt-2+ (cytotoxic-suppressive) T lymphocytes are needed for elimination of the virus and also regulate the humoral response but that antiviral antibodies are not essential for control of the infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494855      PMCID: PMC254192          DOI: 10.1128/JVI.61.6.1867-1874.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.

Authors:  N L Gutstein; D Wofsy
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

2.  Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage.

Authors:  G S Wood; N L Warner; R A Warnke
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

3.  Tumor therapy with monoclonal antibodies.

Authors:  R Levy; R A Miller
Journal:  Fed Proc       Date:  1983-06

4.  The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes.

Authors:  R J Kurlander; D M Ellison; J Hall
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

5.  Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens.

Authors:  S L Swain; D P Dialynas; F W Fitch; M English
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

6.  Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.

Authors:  W E Seaman; D Wofsy; J S Greenspan; J A Ledbetter
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo.

Authors:  J A Byrne; M B Oldstone
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

8.  Immunotherapy of lymphoid and nonlymphoid tumors with monoclonal anti-Lyt-1 antibodies.

Authors:  N Hollander
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

9.  Regulation of natural killer cell activity by anti-I-region monoclonal antibodies.

Authors:  S D Sharma; T Budzich; M R Proffitt; D Shepherd; J S Remington
Journal:  Cell Immunol       Date:  1984-04-15       Impact factor: 4.868

10.  Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.

Authors:  R Ahmed; A Salmi; L D Butler; J M Chiller; M B Oldstone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  66 in total

1.  Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.

Authors:  P Seiler; B M Senn; P Klenerman; U Kalinke; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 2.  T cells in the central nervous system: the delicate balance between viral clearance and disease.

Authors:  Dorian B McGavern; Dirk Homann; Michael B A Oldstone
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

3.  An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.

Authors:  Andrew Stamm; Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  Virology       Date:  2012-02-04       Impact factor: 3.616

4.  Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice.

Authors:  D G Quinn; A J Zajac; C E Hioe; J A Frelinger
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Trojan horse lymphocytes: a vesicular stomatitis virus-specific T-cell clone lyses target cells by carrying virus.

Authors:  R C Hom; G Soman; R Finberg
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  The complementary roles of cellular and humoral immunity in resistance to re-infection with LCM virus.

Authors:  A R Thomsen; O Marker
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

7.  Genetic analysis of in vivo-selected viral variants causing chronic infection: importance of mutation in the L RNA segment of lymphocytic choriomeningitis virus.

Authors:  R Ahmed; R S Simon; M Matloubian; S R Kolhekar; P J Southern; D M Freedman
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

8.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus.

Authors:  V J La Posta; D D Auperin; R Kamin-Lewis; G A Cole
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation.

Authors:  Patrick Lacasse; Jérôme Denis; Réjean Lapointe; Denis Leclerc; Alain Lamarre
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.